OraSure Says CDC Has Placed
an Order for Its Oral HIV Test
CDC recently placed a $2.3 million bulk order for the rapid OraQuick HIV-1/2 test - which can provide results in 20 minutes using oral fluid, finger stick, and venous whole blood, or plasma samples - test maker OraSure Technologies Inc. said Thursday. It is CDC's third such purchase since 2003 and is intended to help meet growing demand for the rapid test among public health groups, according to OraSure. The company said it is in negotiations with federal agencies and several municipalities about additional orders later this year, and it has asked the Food and Drug Administration to approve over-the-counter sales so consumers could take the test at home.
You can also join the
PreventioNews listserv from the NPIN Web site at:
[Back to HIV/STD News]